Shenzhen Hepalink Pharmaceutical Group Co Ltd

Common Name
Hepalink
Country
China (Mainland)
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
1,926
Ticker
002399
Exchange
SHENZHEN STOCK EXCHANGE
Description
Shenzhen Hepalink Pharmaceutical Group Co., Ltd. is a prominent pharmaceutical company specializing in the production and distribution of heparin and related products. Heparin, a critical anticoagulan...

Hepalink's GHG Emissions Data Preview

In 2023, Hepalink completed a corporate carbon footprint assessment and publicly disclosed its greenhouse gas (GHG) emissions according to the GHG Protocol, covering Scope 1 (direct emissions from owned or controlled sources), and Scope 2 (indirect emissions from purchased energy).

However, Hepalink has not published a category-level breakdown of its Scope 3 emissions, limiting visibility into specific value chain sources.

Metric (tCO2e)2024202320222021 - 2017
Total Scope 1
0000000
Copy restricted. Please purchase to unlock this data.
Copy restricted. Please purchase to unlock this data.
0000000
Total Scope 2
Unspecified Calculation Method
0000000
Copy restricted. Please purchase to unlock this data.
Copy restricted. Please purchase to unlock this data.
0000000
Total Scope 3
0000000
Copy restricted. Please purchase to unlock this data.
Copy restricted. Please purchase to unlock this data.
0000000

This table provides a simplified preview of selected GHG emissions data points. To access the complete dataset with full disclosures, detailed breakdowns, and source traceability, create a free account to view purchase options.

Insights into Hepalink's Operational Emissions

In 2023, the total operational greenhouse gas (GHG) emissions of Hepalink amounted to 55,874.1 metric tons of CO2 equivalent. This figure includes both direct emissions from owned or controlled sources (Scope 1) and indirect emissions from purchased energy (Scope 2).

Compared to 2022, the total operational greenhouse gas (GHG) emissions of Hepalink decreased by 4.24%, showing that the company has made progress in taking action to reduce the climate impact of its operations.

Hepalink's Scope 1 Emissions Over Time

2022202306.5 k13 k19.5 k26 ktCO2e+1%
  • Total Scope 1
  • Year-over-Year Change

What are Hepalink's Scope 1 emissions?

In 2023, the total Scope 1 emissions of Hepalink were 24,672.9 metric tons of COâ‚‚ equivalent (tCOâ‚‚e).

Compared to the previous year (2022), Hepalink's Scope 1 emissions increased by 1.3%, suggesting that the company faced challenges in reducing emissions from its directly owned or controlled operations.

What are Hepalink's Scope 2 emissions?

In 2023, Hepalink reported Scope 2 greenhouse gas (GHG) emissions of 31,201.2 tCOâ‚‚e without specifying the calculation method.

Has Hepalink reduced its Scope 2 emissions over time?

Compared to the previous year (2022), Hepalink's Scope 2 emissions (Unspecified Calculation Method) have remained relatively stable, indicating that Hepalink 's emissions have plateaued with no significant change in its energy consumption footprint.

What methodology does Hepalink use for Scope 2 reporting?

In 2023, Hepalink reported its Scope 2 emissions using an unspecified methodology.

Hepalink's Scope 2 Emissions Over Time

2022202308.5 k17 k25.5 k34 ktCO2e
  • Total Scope 2 (Unspecified Calculation Method)